Diagnostics & Research
News & analysis
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).Qiagen NV provides sample and assay technologies to extract, purify, amplify, and interpret DNA (Deoxyribonucleic acid), RNA (Ribonucleic acid), and proteins. It also offers kits, assays, related automated systems and bioinformatics solutions.
Latest QIA News